To validate this finding, we obtained two BET inhibitors (JQ1 and AZD5153) and three DLBCL cell lines (SU-DHL-5, HT, and Toledo) to repeat the experiment. The gene discussed is DNER; the disease is diffuse large B-cell lymphoma.